PASCAL Shows Excellent Short-Term, Sustained Survival, MR Reduction

News

PASCAL Shows Excellent Short-Term, Sustained Survival, MR Reduction

Posted: 06/25/2020
Author:
Charan Yerasi, CRTonline.org

The CLASP study shows low complication rates, with a sustained reduction in mitral regurgitation and improved clinical outcomes, with the PASCAL transcatheter valve repair system.

Most Viewed Pages

Exercise Can Change Your Mind: Physical Activity’s CVD Benefits Linked to Stress-Related Neural Pathways

Live Case | Broadcasting from Tucson Medical Center | Tucson, AZ

Live Case | Broadcasting from Tucson Medical Center | Tucson, AZ

Abiomed’s Updated Instructions for Certain Impella Pumps Identified as Class I Action: FDA

Live Case Broadcasting from MedStar Washington Hospital Center | Washington, DC

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

News

PASCAL Shows Excellent Short-Term, Sustained Survival, MR Reduction

Most Viewed Pages

Explore the Site

Stay Connected